Posted on 12/09/2022
12th September 2022. Worthing, United Kingdom. Rayner, the pioneering manufacturer and supplier of ophthalmic solutions for cataract and refractive surgery, today announced the global launch of RayPRO+ at the upcoming ESCRS 2022 congress in Milan. An evolution of RayPRO: Rayner’s proprietary mobile app and web-based digital platform that proactively collects an insightful blend of Patient
Posted on 30/08/2022
Rayner sponsors ESCRS satellite symposium When: Sunday 18th September, 13.00-14.00 Where: Room Blue 2 Professor Oliver Findl (Austria), Professor Gerd Auffarth (Germany), Mr Allon Barsam (United Kingdom), Dr Başak Bostanci (Turkey) and Dr Tiago Ferreira (Portugal) complete the panel of surgeons for the Rayner-sponsored satellite symposium: Challenges in cataract surgery and advanced technology IOL solutions.
Posted on 1/08/2022
Worthing-based Rayner today announced the launch of its new patient education toolkit: YourVision.YourWorld. Comprising an extensive suite of digital and print materials, the toolkit has been created to help patients navigate cataract surgery and the increasing number of intraocular lens (IOL) options available to them. Patients with visual and cognitive impairments will benefit from the
Posted on 11/07/2022
Worthing, United Kingdom. Leading ophthalmology company Rayner has today announced its direct entry into the French cataract and refractive market. Based out of Lille in the Hauts-de-France region, Rayner has a growing team of experienced Ophthalmic Specialist Area Managers, focused on delivering the highest levels of service and support. Through this team, French ophthalmologists now
Posted on 29/06/2022
Today, Rayner has launched Peer2Peer: a global KOL-led clinical education program focused on the most important topics in cataract and refractive surgery – including presbyopia correction, advanced IOL design, astigmatism correction, dry eye management and digital health. Peer2Peer is an evolution of Rayner’s ‘Plus1 EMV’ program; now with first users, experienced users and thought provokers
Posted on 8/06/2022
Worthing, United Kingdom. Rayner, the pioneering manufacturer and supplier of ophthalmic solutions for cataract and refractive surgery, announced today that it has entered into a commercial partnership and concurrently acquired a stake in HASA OPTIX. The investment closed June 7th, 2022. Investment Details Rayner has entered into a commercial partnership with Brussels-based medical device company
Posted on 31/05/2022
May 19, 2022 – Worthing-based Rayner, a global innovator in cataract and refractive surgery solutions and the only UK manufacturer of intraocular lenses (IOLs), announced today that AEON, its surgery-focused premium eye drops are now available in one of the leading UK optician chains, Boots Opticians, with more than 500 branches across the UK. In the UK,
Posted on 22/02/2022
FEBRUARY 22 2022 – Worthing, United Kingdom. Rayner, a global innovator in cataract and refractive surgery, announced today that it has agreed a development partnership with Wolffsohn Research Ltd to accelerate the development of its Digital Health platform. Rayner launched RayPRO, a digital platform to collect patient reported outcomes (PRO), in 2019 and has since collected data
Posted on 19/01/2022
JANUARY 19, 2022 – Worthing, United Kingdom. Rayner, a leading ophthalmology company and the only British manufacturer of intraocular lenses (IOLs), announced today that it now has a direct sales presence in Australia as it continues its global commercial expansion. Previously distributed through Designs For Vision, Rayner will now sell its products directly to surgeons and hospitals
Posted on 5/01/2022
JANUARY 05, 2022 – Worthing, United Kingdom. Rayner, the only UK manufacturer of intraocular lenses (IOLs), today announced the launch of RayOne Hydrophobic BLF. Made of its proprietary ultra glistening-free hydrophobic material, RayOne Hydrophobic BLF is Rayner’s first blue light filtering IOL. RayOne Hydrophobic BLF expands Rayner’s RayOne lens portfolio from seven to eight variants, now with